Zimmer Biomet flags $60m-$80m tariff impact on 2025 profits
Zimmer Biomet has adjusted its 2025 earnings forecast to $7.90-$8.10 per share, down from previous estimates falling between $8.15-$8.35, due to the Trump administration's tariffs.
The orthopaedic giant's stock fell by almost 12% after revealing on 5 May that tariffs would contribute to a $60m-$80m drag on its operating profit in 2025.
Zimmer elaborated on the revised projections in its Q1 2025 earnings call. During the quarter, the company achieved around $1.9bn in net sales, indicative of a 1.1% increase on a constant currency basis.
Zimmer's chief financial officer and finance, operations and supply chain EVP Suketu Upadhyay noted that while the tariff situation 'remains fluid', the company anticipates an impact of a '$60m to $80m' headwind to operating profit in 2025, with the 'majority' of the impact falling in the second half of the year.
Upadhyay said: 'This estimate contemplates our latest view of mitigation efforts currently underway and that the announced European reciprocal tariffs will go into effect after the 90-day stay period.'
Along with Zimmer's recent $1.2bn acquisition of Paragon 28 earlier this year, due to tariffs, the company anticipates its full-year operating margins to be down by 100 to 150 basis points versus 2024.
Upadhyay added: 'I will note that our 2025 impact should not be used as a run rate for 2026 due to a variety of factors, and that our estimate around the impact of tariffs in 2025 could change as the macro environment continues to unfold.'
While noting that the majority of its manufacturing is undertaken within the US, Zimmer also has manufacturing sites in the Chinese cities of Jintan and Zhejiang.
Trump's tariffs have heavily targeted China, with levies rising since the nation imposed 34% tariffs in response to those Trump announced would come into force on Chinese imports on 9 April. While the president has since stated that levies for goods imported from the country will 'come down substantially' yet 'won't be zero', they remain at 145% for now.
To mitigate some of the tariff impact, Upadhyay also shared that Zimmer is optimising 'in our view of country of origin', potentially alluding to a diminishment in its China-based manufacturing activities.
Other players in the medtech space are attempting to factor in the impact the Trump administration's current tariff measures may have on their bottom line in 2025.
Anticipating that its 2025 revenues may take a hit of around $500m, imaging giant GE HealthCare has downshifted its earnings per share profit to fall within the $3.90-$4.10 per share range, down from previous guidance between $4.61 and $4.75 per share.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
19 minutes ago
- Yahoo
Factbox-Breakdown of U.S. tariffs on China since Trump's first term
BEIJING (Reuters) -Billions of dollars of Chinese goods have been impacted by additional U.S. tariffs since 2018, initially under the first Donald Trump presidency and later under the Biden administration. Returning to the White House this year, Trump has imposed even more duties on China. The U.S. tariffs range from those imposed under Section 301 of its trade act due to what Washington claims are unfair Chinese trade practices, to duties under Section 232 levied for national security reasons. This year, Trump has imposed another 20% levies on all Chinese goods, saying Beijing has not done enough to stop the flow of fentanyl into the United States. So-called reciprocal tariffs, under which the U.S. will match duties imposed by other countries, have also been levied in a bid to rebalance trade flows. Below are the U.S. tariffs on China effective as of June 12, 2025: Tariff Rate Products Effective date Reciprocal 10% All Paused for 90 days until Aug 10, 2025 Fentanyl 20% All Mar 4, 2025 Section Up to List 1: Pharmaceuticals, July 6, 2018 301 25% iron and steel, aluminium, vehicles and aircraft, medical or surgical instruments and apparatus and more. List 2: Vehicles, Aug 23, 2018 railway or tramway locomotives, aircraft and their parts, medical or surgical instruments and apparatus and more. List 3: Prepared May 10, 2019 foodstuffs, beverages, mineral products, fertilizers, wood products, textiles, precious and base metals, vehicles, aircraft, vessels, machinery and mechanical appliances and more. List 4A: Prepared Feb 14, 2020 foodstuffs, beverages, mineral products, fertilizers, footwear, wood products, ceramic products, glass, textiles, precious and base metals, machinery and mechanical appliances, vehicles, aircraft, vessels, art, antiques and more. In September 2019, the U.S. imposed 15% tariffs on more than $120 billion of Chinese goods under Section 301, which it then halved to 7.5% less than six months later. The 25% U.S. tariffs on $250 billion of Chinese goods under the earlier List 1-3 remain unchanged. In September 2024, the U.S. Trade Representative under the Biden administration announced additional tariffs of 25-100% on 14 product groups following a four-year review of the Section 301 tariff actions. The levies were imposed on strategic Chinese sectors or sectors where the United States has made significant domestic investments. Additional tariffs on goods under Section 301: Effective date EVs 100% Sep 27, 2024 Solar cells, syringes and 50% needles Non-lithium-ion battery parts, 25% lithium-ion electrical vehicle batteries, other critical minerals, ship-to-shore cranes, steel and aluminium products, facemasks Semiconductors 50% Jan 1, 2025 Lithium-ion non-electrical 25% Jan 1, 2026 vehicle batteries, medical gloves, natural graphite, permanent magnets In addition to the above duties, the first Trump administration in 2018 imposed a range of tariffs under Section 232 aimed at restricting goods deemed a threat to national security, including all aluminium and steel imports, shutting most Chinese suppliers out of the U.S. market. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
CNBC
25 minutes ago
- CNBC
U.S. uncertainty is handing Europe a huge opportunity
Europe is being urged to capitalize on the volatility of the Trump administration, as shifts in capital and private market flows suggest U.S. exceptionalism is waning and losing out to a resurgent Europe. The numbers tell part of the story, with Europe's Stoxx 600 up over 8% compared to a 5% jump for the S&P 500 since Nov. 1, 2024, just days ahead of the U.S. election. Bank of America said in a report dated June 5 that U.S. equities had seen outflows of $7.5 billion over the previous three weeks, while European stocks benefited from inflows of $2.6 billion over the same period. Earlier this year, meanwhile, data from Morningstar showed that investors withdrew 2.8 billion euros ($3.2 billion) from U.S. equity ETFs in the month to the middle of March, while shifting 14.6 billion euros into European ETFs. Goldman Sachs International Co-CEO Anthony Gutman told CNBC that the convergence in U.S. and European growth rates came about quickly this year and was a big factor prompting investors to shift money toward Europe. "In January, sentiment felt very strong in the U.S., it felt somewhat more muted in Europe. You roll the clock forward and now the picture has changed fairly dramatically, that's to the benefit of Europe in many cases. Europe is getting more capital inflows and there is more optimism in Europe," Gutman told CNBC's Annette Weisbach Wednesday on the sidelines of the Goldman Sachs European Financials Conference in Berlin. Meanwhile, in private markets, talk of the breakdown of U.S. exceptionalism dominated the Super Return forum in Berlin last week. Carlyle Group's Managing Director Mark Jenkins told CNBC that, "in Europe, we've seen a lot of great opportunity and think we can pick up greater returns here relative to the risk you're taking in the U.S." This sentiment was echoed by private equity giant Permira, which holds private equity funds and credit vehicles representing around 60 billion euros worth of capital under management. "If you look at Europe at the moment, firstly, capital is cheaper, if you look at the trend of where euro rates are going versus dollar rates are going, you can fund and finance things cheaper here. Secondly, valuations are cheaper, you can buy great companies for less," Permira Executive Chairman Kurt Björklund told CNBC's "Squawk Box Europe" on Tuesday. "Thirdly the innovation cycle is growing exponentially in Europe … there is an enormous number of highly innovative companies that are growing in a disruptive and global way," he added. All eyes are now on the potential for an EU-U.S. trade deal — which is proving trickier to pin down than with some other countries, including the U.K. Referencing the complexity of the behemoth that is the European Union, Siemens Energy Chairman Joe Kaeser told CNBC that the EU is "politically not ready to strike these types of deals." The White House hinted on Wednesday that a July 9 deadline for a deal may be movable, however, with Treasury Secretary Scott Bessent saying: "It is highly likely that for those countries that are negotiating — or trading blocs, in the case of the EU — who are negotiating in good faith, we will roll the date forward to continue the good faith negotiation." French President Emmanuel Macron also struck an optimistic tone, telling CNBC's Karen Tso on Wednesday: "I'm sure that we will find, at the end of the day, a good solution." Unicredit CEO Andrea Orcel stressed that the opportunity for Europe's continued revival lies in its own hands, however. He explained that the 27-member European Union could galvanize amid the fracturing of Europe's relationship with the U.S., but warned that investors can also be fickle. The expectation is that "there will be convergence, there will be a banking union, there will be a capital markets union. There will be a lot of spend on infrastructure, on defense... That's exciting for the market, therefore money flowing in," Orcel told CNBC Wednesday. "But if, little by little, investors realize that this is lip service, but it doesn't really happen. Money will flow back in a nanosecond, and you will see [that] very quickly." Europe is faced with a "phenomenal opportunity," he added. "We have every reason to be ... on par with the U.S., but it's our fault if we don't do it."
Yahoo
26 minutes ago
- Yahoo
China affirms trade deal with US, says it always keeps its word
BEIJING (Reuters) -China on Thursday affirmed a trade deal announced by U.S. President Donald Trump, saying both sides needed to abide by the consensus and adding China always kept its word. The deal, reached after Trump and China's President Xi Jinping spoke on the telephone last week, brings a delicate truce in a trade war between the world's two largest economies. "China has always kept its word and delivered results," Lin Jian, a foreign ministry spokesperson, said at a regular news conference. "Now that a consensus has been reached, both sides should abide by it." The Trump-Xi telephone call broke a standoff that had flared just weeks after a preliminary deal was reached in Geneva. The call was quickly followed by more talks in London that Washington said had put "meat on the bones" of the Geneva agreement to ease bilateral retaliatory tariffs. The Geneva deal had faltered over China's continued curbs on minerals exports, prompting the Trump administration to respond with export controls preventing shipments of semiconductor design software, jet engines for Chinese-made planes and other goods to China. Trump on Wednesday said he was very happy with the trade deal. "Our deal with China is done, subject to final approval with President Xi and me," Trump said on Truth Social. "Full magnets, and any necessary rare earths, will be supplied, up front, by China. Likewise, we will provide to China what was agreed to, including Chinese students using our colleges and universities (which has always been good with me!). We are getting a total of 55% tariffs, China is getting 10%." Still, specifics of the latest deal and details on how it will be implemented remain unclear. A White House official said the 55% represents the sum of a baseline 10% "reciprocal" tariff Trump has imposed on goods imported from nearly all U.S. trading partners, 20% on all Chinese imports associated with his accusation that China had not done enough to stem the flow of fentanyl into the U.S., and pre-existing 25% levies on imports from China put in place during Trump's first presidential term. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
